Flavonoid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

Flavonoid Market Analysis

The flavonoids market size is valued at USD 1.42 billion in 2025 and is expected to reach USD 1.82 billion by 2030, growing at a CAGR of 5.11%. The market growth is driven by regulations supporting natural colorants, improved extraction technologies, and increased consumer demand for functional nutraceuticals and cosmetics. The Food and Drug Administration's amendment to color additive regulations now permits the expanded use of butterfly pea flower extract in various food products, including ready-to-eat cereals, crackers, snack mixes, hard pretzels, plain potato chips, corn chips, tortilla chips, and multigrain chips at levels aligned with good manufacturing practice (GMP). This regulatory change, effective June 26, 2025, responds to a color additive petition (CAP) from Sensient Colors, LLC, and indicates an industry shift toward botanical pigments. Moreover, Ohio State University's development of shelf-stable anthocyanin blues enhances functionality in acidic environments. North America dominates the market due to established FDA guidelines, while the Asia-Pacific region shows growth driven by increasing disposable income and favorable nutraceutical regulations. Supply constraints in citrus and berries affect raw material availability; however, fermentation-based production methods offer potential solutions to stabilize price fluctuations.

Global Flavonoid Market Trends and Insights

Growing Demand for Anti-Inflammatory Joint Health Supplements

The increasing elderly population and growing focus on preventive healthcare drive the demand for flavonoids in joint health applications, as quercetin and other flavonoids show proven anti-inflammatory properties. In February 2025, the Food and Drug Administration's final rule updated the definition of "healthy" as an implied nutrient content claim to align with current nutrition science and Federal dietary guidance, particularly the Dietary Guidelines for Americans. This revision establishes requirements for using "healthy" in human food product labeling, helping consumers identify nutritious foods that align with dietary recommendations and encouraging manufacturers to fortify snacks and beverages with flavonoids that meet nutrient-density criteria. The nutraceutical market continues to consume higher volumes, maintaining premium raw-material prices despite increased competition. The combination of flavonoids with conventional active ingredients reduces pill consumption and improves consumer adherence, establishing flavonoids as complementary ingredients rather than replacements. The industry's focus on joint-health claims is evidenced by investments in pilot-scale encapsulation facilities.

Antiviral and Antimicrobial Applications in Natural Remedies

Growing health awareness drives the incorporation of flavonoids in immune support products, as compounds such as baicalin and baicalein demonstrate proven antiviral and antimicrobial effects in clinical studies. The therapeutic use of flavonoids increases as regulatory bodies in Asian countries, especially China and India, recognize traditional herbal medicines containing these compounds, establishing comprehensive market entry pathways and standardized approval processes. Asian nutraceutical regulations emphasize stringent safety and efficacy standards, favoring scientifically validated flavonoid compounds through extensive research and documentation requirements. The ability of flavonoids to serve both preventive and therapeutic functions strengthens their position in the immune health market, particularly as consumers seek natural alternatives supported by robust scientific evidence and clinical validation. This dual functionality, combined with increasing regulatory acceptance and consumer demand, creates significant opportunities for manufacturers developing flavonoid-based immune support products.

Limited Shelf Life

The degradation of flavonoids during storage and processing creates significant technical and economic challenges for market growth, particularly in applications requiring long shelf life. The stability of anthocyanins heavily depends on environmental factors such as pH levels, temperature conditions, and light exposure, which directly affect their biological effectiveness and commercial viability in various applications. Advanced encapsulation technologies and co-pigmentation methods, while effective in improving stability, significantly increase production costs and add complexity to manufacturing processes. Anthocyanin-based intelligent packaging systems function as comprehensive pH indicators, providing sophisticated color-change capabilities for continuous product monitoring throughout the supply chain. Ongoing research on flavonoid-based nanogels demonstrates considerable potential for improved stability and bioavailability, though scaling these solutions for commercial production remains technically challenging. These stability concerns primarily impact the food and beverage industry, where natural colorants must consistently maintain their visual and functional properties throughout extended distribution and storage periods, often lasting several months.

Other drivers and restraints analyzed in the detailed report include:

1. Use as Natural Colorants in Food and Beverage
2. Increasing Demand for Anti-Bacterial Properties in Skincare Products
3. Dependency on Seasonal and Regional Crop Supply

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Anthocyanins dominated the Flavonoids market with a 29.53% share in 2024, driven by their applications as natural colorants and antioxidants. Recent regulatory approvals for butterfly pea and increased demand for natural blue colors in beverage reformulations support this segment's growth. Flavonols, particularly quercetin, demonstrate a 6.37% CAGR, supported by expanding applications in cardiovascular and metabolic health. Recent developments in water-soluble 3-hydroxyflavonol technology enhance bioavailability, increasing clinical applications. Flavan-3-ols maintain stable growth due to FDA cardiovascular qualified health claims for cocoa powders, while flavones and isoflavones serve specific hormonal health applications. During the forecast period, increased therapeutic validation and pharmaceutical trials position flavonols to reduce the market share gap.

The market for flavonols continues to expand through ongoing research and development, while anthocyanins maintain their market position through color innovation. Manufacturers gain competitive advantages through improved stability technologies, securing premium contracts with major beverage and beauty companies. Growing clinical evidence for flavonol efficacy is expected to increase healthcare provider acceptance and expand over-the-counter availability, facilitating broader market penetration in mainstream health channels.

Berries contributed 27.45% of the Flavonoids market size in 2024, supported by established supply chains and widespread use of blueberry and blackcurrant extracts. However, climate-related yield variations create price volatility that affects processor margins. The herbs and spices segment grows at 6.64% CAGR, supported by the continuous cultivation of Scutellaria and rosemary, which provide concentrated active compounds at lower doses. Citrus maintains its market position through efficient hesperidin production, though disease and drought concerns lead to geographic diversification of sources. Soybean isoflavones serve the menopause support segment, while tea and cocoa maintain stable demand due to traditional consumption patterns.

Manufacturers distribute sourcing across hemispheres to minimize weather-related disruptions and maintain market stability. Fermentation facilities test baicalin production using stainless-steel bioreactors, reducing dependence on crop cycles and minimizing pesticide exposure. This approach ensures consistent quality and meets environmental, social, and governance (ESG) requirements, positioning herb-derived and fermentation-derived flavonoids as risk management tools. As regulatory requirements for product disclosure increase, supply chain traceability becomes crucial in supplier selection, benefiting sources with comprehensive audit systems.

The Global Flavonoids Market Report is Segmented by Type (Anthocyanin, Flavones, Isoflavones, Flavanol, and More), Source (Citrus Fruits, Berries, and More), Form (Powder, Liquid, and Others) Application (Food and Beverages, Nutraceutical, Pharmaceutical, and More); and by Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America accounted for 32.45% of 2024 revenue, supported by FDA health-claim clarity and established supplement distribution channels. The region faces challenges from citrus greening disease and extreme weather conditions, driving companies to source ingredients from Latin America or through fermentation processes. IFF's USD 70 million investment in February 2025 to expand its Cedar Rapids, Iowa, facility by 47,000 square feet demonstrates a commitment to domestic production. The expansion, scheduled for completion in 2026, will increase Taura by IFF fruit ingredients production to serve the healthy snacks market. While retailers value U.S.-grown ingredients, buyers accept imported alternatives during domestic supply shortages and price increases.

Asia-Pacific shows the highest growth rate at 6.42% CAGR, driven by expanding middle-class consumption, acceptance of traditional medicine, and emerging manufacturing centers. China's incorporation of validated flavonoids in its functional-food catalogue and India's Ayurvedic standards create efficient approval processes, reducing time-to-market. The expansion of e-commerce beyond urban areas increases market penetration and sales volume.

Europe maintains consistent growth, supported by strict additive regulations and environmentally conscious consumers. EFSA's reassessment of existing colorants creates opportunities for flavonoid alternatives that avoid extensive toxicological reviews. Ongoing drought conditions reduce EU citrus production, limiting regional hesperidin availability and increasing interest in Blackcurrant and Elderberry alternatives. The cosmetics industry in France and Italy benefits from comprehensive regulations covering 309 approved colorants, facilitating faster development of skincare products containing flavonoids.

List of Companies Covered in this Report:

1. Indena S.p.A
2. Layn Natural Ingredients
3. The Merck Group
4. Cayman Chemical Company
5. Extrasynthese
6. Foodchem International Corporation
7. DSM-Firmenich AG
8. The Archer-Daniels-Midland Company
9. Cargill, Incorporated
10. Givaudan S.A.
11. Alps Pharmaceutical Ind. Co., Ltd
12. Sabinsa Corporation
13. Synthite Industries Ltd.
14. Kemin Industries Inc.
15. Evolva Holding SA
16. Blue California, Inc.
17. Bioriginal Food & Science Corp.
18. Ingredients By Nature
19. Venkatesh Natural Extract Pvt. Ltd.
20. INDOFINE Chemical Company, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support